C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/06 (2006.01) A61K 31/4375 (2006.01) A61K 31/55 (2006.01) A61K 31/551 (2006.01) A61P 35/00 (2006.01) C07D 209/00 (2006.01) C07D 221/00 (2006.01) C07D 223/00 (2006.01) C07D 243/00 (2006.01) C07D 487/00 (2006.01) C07D 487/06 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2360003
Compounds of formula (I) are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.
Cette invention concerne des composés représentés par la formule (I) ci-dessous qui sont des inhibiteurs de la poly(ADP-ribosyl)transferase (PARP) et qui sont utiles pour le traitement des cancers et atténuent les effets d'attaques, de traumatismes crâniens et des maladies neurodégénératives. En tant qu'agents thérapeutiques des cancers, les composés selon l'invention peuvent s'employer notamment en combinaison avec des agents cytotoxiques et/ou des rayons.
Canan-Koch Stacie S.
Thoresen Lars Henrik
Tikhe Jayashree
Webber Stephen Evan
Agouron Pharmaceuticals Inc.
Cancer Research Campaign Technology Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Tricyclic inhibitors of poly(adp-ribose) polymerases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic inhibitors of poly(adp-ribose) polymerases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic inhibitors of poly(adp-ribose) polymerases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1865518